New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 31, 2014
08:41 EDTROSGRosetta Genomics announces Alzheimer's agreement with global pharma company
Rosetta Genomics announces that it has signed an agreement with a global pharmaceutical company, or GPC, in the area of Alzheimer's disease, or AD, diagnostics. Under the agreement, Rosetta will provide its microRNA profiling and other services to assist in the development of a microRNA-based diagnostic for the early detection of AD. Rosetta will leverage the GPC's expertise in AD as it is considered a pioneer in the development and commercialization of therapeutics for AD.
News For ROSG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 16, 2015
08:32 EDTROSGRosetta Genomics announces agreement with MultiPlan for PersonalizeDx suite
Rosetta Genomics announces that PersonalizeDx, a Rosetta Genomics company, has executed a network participation agreement with MultiPlan for the entire suite of PersonalizeDx testing and services effective July 1. MultiPlan provides healthcare cost management solutions, including preferred provider networks. More than 900,000 healthcare providers participate in MultiPlanís networks, and the company reprices 40 million claims each year. It is estimated that 68 million Americans have access to MultiPlanís networks. In addition to offering regional PPO networks in Wisconsin and the southwest, Multi-Plan offers the leading independent national primary PPO and one of the largest complementary networks in the United States. As a result of this agreement, PersonalizeDx is one of those participating healthcare providers.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use